Cargando…
High PTX3 expression is associated with a poor prognosis in diffuse large B‐cell lymphoma
Tumor‐associated macrophages (TAMs) are associated with a poor prognosis of diffuse large B‐cell lymphoma (DLBCL). As macrophages are heterogeneous, the immune polarization and their pathological role warrant further study. We characterized the microenvironment of DLBCL by immunohistochemistry in a...
Autores principales: | Carreras, Joaquim, Kikuti, Yara Yukie, Hiraiwa, Shinichiro, Miyaoka, Masashi, Tomita, Sakura, Ikoma, Haruka, Ito, Atsushi, Kondo, Yusuke, Itoh, Johbu, Roncador, Giovanna, Martinez, Antonio, Colomo, Lluis, Hamoudi, Rifat, Ando, Kiyoshi, Nakamura, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748251/ https://www.ncbi.nlm.nih.gov/pubmed/34706126 http://dx.doi.org/10.1111/cas.15179 |
Ejemplares similares
-
Artificial Neural Networks Predicted the Overall Survival and Molecular Subtypes of Diffuse Large B-Cell Lymphoma Using a Pancancer Immune-Oncology Panel
por: Carreras, Joaquim, et al.
Publicado: (2021) -
Mutational Profile and Pathological Features of a Case of Interleukin-10 and RGS1-Positive Spindle Cell Variant Diffuse Large B-Cell Lymphoma
por: Carreras, Joaquim, et al.
Publicado: (2023) -
High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation
por: Carreras, Joaquim, et al.
Publicado: (2019) -
Copy Number Alteration and Mutational Profile of High-Grade B-Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements, Diffuse Large B-Cell Lymphoma with MYC-Rearrangement, and Diffuse Large B-Cell Lymphoma with MYC-Cluster Amplification
por: Miyaoka, Masashi, et al.
Publicado: (2022) -
Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels
por: Carreras, Joaquim, et al.
Publicado: (2022)